Abstract: A power adapter, including a main body having a housing and pins connected to the housing, a synchronization mechanism connected to the housing, a first cover body, connected to the synchronization mechanism and moving relative to the housing to a first position and a second position, and a second cover body connected to the synchronization mechanism and driven by the synchronization mechanism during the movement of the first cover body relative to the housing to achieve the synchronous movement of the second cover body and the first cover body.

Abstract: This invention provides the use of specialized proresolving mediators (SPMs) for use as melanocyte growth promoters and pro-survival factors. More particularly, the SPM compositions are suitable for promoting melanocyte growth and/or survival to prevent depigmentation of melanocytes and/or promoting repigmentation in non-inflammatory depigmentation of melanocytes. Furthermore, the compositions may be used to treat dormant vitiligo lesions, chemically induced vitiligo, vitiligo that is non-responsive to inflammatory therapies, or canities.

Abstract: Provided is an electronic device, including a housing assembly, a tension assembly, and a flexible screen module. The housing assembly includes a first housing having a first supporting surface, and a second housing having a second supporting surface. The tension assembly is connected to the housing assembly. The flexible screen module has a fixed end connected to the first housing and supported by the first supporting surface, and a free end connected to the tension assembly and bypassing an end of the second housing facing away from the first housing and extending into the housing assembly. The first housing is movable relative to the second housing, enabling at least a part of the flexible screen module to unfold on the second supporting surface or to retract into the housing assembly.

Abstract: It discloses a compound of formula I that inhibits the activities of numerous of protein kinases involving the signaling of inflammatory cytokines, therefore, the compound can be used for treating cancers, autoimmune diseases and inflammatory diseases.

Abstract: Disclosed herein are methods for treating skin conditions associated with skin parasites, including mites, by administering a therapeutically effective amount of 3,5-dihydroxy-4-isopropyl-trans-stilbene (DHIS).

Abstract: Described are methods for reducing the proliferation cancer cells by modulating the expression or activity of TOX such as by use of a TOX inhibitor. Inhibiting TOX expression with antisense nucleic acids is shown to reduce the proliferation of malignant T cells. Also described are methods for the treatment of cancer in a subject in need thereof comprising administering to the subject a TOX inhibitor. Optionally, the cancer is a T cell malignancy such as Cutaneous T cell Lymphoma (CTCL).

Abstract: Described are biomarkers including TOX useful for the diagnosis or prognosis of T cell malignancy. A level of a biomarker is determined in a sample from a subject and compared to a control level, wherein an increased level of the biomarker in the sample relative to the control level indicates that the subject has T cell malignancy. The T cell malignancy may be a cutaneous T cell lymphoma (CTCL) such as mycosis fungoides or Sezary syndrome.